Scilex Holding (SCLX) Receivables (2021 - 2026)
Scilex Holding (SCLX) posted quarterly Receivables of $10.6 million for Q1 2026, little changed year-over-year from $10.6 million in Q1 2025, and down 10.84% quarter-over-quarter from $11.9 million in Q3 2025.
Scilex Holding (SCLX) Receivables (2021 - 2026) Analysis & Trends
Scilex Holding's Receivables history runs 6 years deep, the most recent figure standing at $10.6 million for Q1 2026.
- In Q1 2026, Receivables changed 0.26% year-over-year to $10.6 million; the TTM figure through Mar 2026 stood at $10.6 million (changed 0.26% YoY), while the FY2024 annual figure was $26.4 million, down 23.57% from the prior year.
- Receivables for Q1 2026 stood at $10.6 million, down from $11.9 million in the prior quarter.
- The five-year high for Receivables was $38.0 million in Q2 2024, with the low at $10.6 million in Q1 2025.
- The 5-year median for Receivables is $22.4 million (2023), against an average of $22.9 million.
- The sharpest annual moves came in 2024 and 2025: Receivables surged 92.23% in 2024, then plunged 64.27% in 2025.
- Scilex Holding's Receivables stood at $21.2 million in 2022, then soared by 62.92% to $34.6 million in 2023, then retreated by 23.57% to $26.4 million in 2024, then sank by 54.84% to $11.9 million in 2025, then declined by 10.84% to $10.6 million in 2026.
- Business Quant data shows SCLX's Receivables at $10.6 million in Q1 2026, $11.9 million in Q3 2025, and $16.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.63 Bn | 632.88 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 471.61 Bn | 465.04 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 380.82 Bn | 373.68 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 303.41 Bn | 295.72 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 258.06 Bn | 253.16 Bn | 12.86 Bn | 14.33 Bn |
| 6 | Amgen | 237.46 Bn | 223.47 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 183.34 Bn | 180.16 Bn | 6.22 Bn | 5.90 Bn |
| 8 | Pfizer | 161.82 Bn | 150.12 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Gsk | 105.95 Bn | 101.79 Bn | 8.24 Bn | 10.34 Bn |
| 10 | Scilex Holding | 39.18 Mn | -73.61 Mn | 3.97 Mn | 19.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.65 Mn |
| Sep 30, 2025 | 11.94 Mn |
| Jun 30, 2025 | 16.77 Mn |
| Mar 31, 2025 | 10.62 Mn |
| Dec 31, 2024 | 26.44 Mn |
| Sep 30, 2024 | 31.58 Mn |
| Jun 30, 2024 | 38.00 Mn |
| Mar 31, 2024 | 29.72 Mn |
| Dec 31, 2023 | 34.60 Mn |
| Sep 30, 2023 | 16.43 Mn |
| Jun 30, 2023 | 27.57 Mn |
| Mar 31, 2023 | 22.44 Mn |
| Dec 31, 2022 | 21.24 Mn |
| Dec 31, 2021 | 14.27 Mn |